Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 9
2003 9
2004 27
2005 38
2006 37
2007 48
2008 76
2009 107
2010 86
2011 102
2012 133
2013 99
2014 106
2015 113
2016 142
2017 119
2018 138
2019 154
2020 172
2021 193
2022 186
2023 148
2024 57

Text availability

Article attribute

Article type

Publication date

Search Results

1,711 results

Results by year

Filters applied: . Clear all
Page 1
Metabolic syndrome, obesity and cancer risk.
Belladelli F, Montorsi F, Martini A. Belladelli F, et al. Among authors: montorsi f. Curr Opin Urol. 2022 Nov 1;32(6):594-597. doi: 10.1097/MOU.0000000000001041. Epub 2022 Sep 8. Curr Opin Urol. 2022. PMID: 36081396 Review.
Worldwide Temporal Trends in Penile Length: A Systematic Review and Meta-Analysis.
Belladelli F, Del Giudice F, Glover F, Mulloy E, Muncey W, Basran S, Fallara G, Pozzi E, Montorsi F, Salonia A, Eisenberg ML. Belladelli F, et al. Among authors: montorsi f. World J Mens Health. 2023 Oct;41(4):848-860. doi: 10.5534/wjmh.220203. Epub 2023 Feb 15. World J Mens Health. 2023. PMID: 36792094 Free PMC article.
Overall survival and adverse events after treatment with darolutamide vs. apalutamide vs. enzalutamide for high-risk non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis.
Wenzel M, Nocera L, Collà Ruvolo C, Würnschimmel C, Tian Z, Shariat SF, Saad F, Tilki D, Graefen M, Kluth LA, Briganti A, Mandel P, Montorsi F, Chun FKH, Karakiewicz PI. Wenzel M, et al. Among authors: montorsi f. Prostate Cancer Prostatic Dis. 2022 Feb;25(2):139-148. doi: 10.1038/s41391-021-00395-4. Epub 2021 May 30. Prostate Cancer Prostatic Dis. 2022. PMID: 34054128 Free PMC article. Review.
Chemotherapy and advanced androgen blockage, alone or combined, for metastatic hormone-sensitive prostate cancer a systematic review and meta-analysis.
Fallara G, Robesti D, Nocera L, Raggi D, Marandino L, Belladelli F, Montorsi F, Malavaud B, Ploussard G, Necchi A, Martini A. Fallara G, et al. Among authors: montorsi f. Cancer Treat Rev. 2022 Nov;110:102441. doi: 10.1016/j.ctrv.2022.102441. Epub 2022 Jul 26. Cancer Treat Rev. 2022. PMID: 35939976 Review.
Expression-based subtypes define pathologic response to neoadjuvant immune-checkpoint inhibitors in muscle-invasive bladder cancer.
Robertson AG, Meghani K, Cooley LF, McLaughlin KA, Fall LA, Yu Y, Castro MAA, Groeneveld CS, de Reyniès A, Nazarov VI, Tsvetkov VO, Choy B, Raggi D, Marandino L, Montorsi F, Powles T, Necchi A, Meeks JJ. Robertson AG, et al. Among authors: montorsi f. Nat Commun. 2023 Apr 27;14(1):2126. doi: 10.1038/s41467-023-37568-9. Nat Commun. 2023. PMID: 37105962 Free PMC article.
Reply by Authors.
Chakiryan NH, Dahmen A, Bandini M, Pederzoli F, Marandino L, Albersen M, Roussel E, Zhu Y, Ye DW, Ornellas AA, Catanzaro M, Hakenberg OW, Heidenreich A, Haidl F, Watkin N, Ager M, Chahoud J, Briganti A, Salvioni R, Montorsi F, Necchi A, Spiess PE. Chakiryan NH, et al. Among authors: montorsi f. J Urol. 2021 Oct;206(4):969. doi: 10.1097/JU.0000000000001790.02. Epub 2021 Aug 11. J Urol. 2021. PMID: 34379451 No abstract available.
Renal cancer: overdiagnosis and overtreatment.
Rosiello G, Larcher A, Montorsi F, Capitanio U. Rosiello G, et al. Among authors: montorsi f. World J Urol. 2021 Aug;39(8):2821-2823. doi: 10.1007/s00345-021-03798-z. World J Urol. 2021. PMID: 34383133 No abstract available.
Neoadjuvant Pembrolizumab and Radical Cystectomy in Patients with Muscle-Invasive Urothelial Bladder Cancer: 3-Year Median Follow-Up Update of PURE-01 Trial.
Basile G, Bandini M, Gibb EA, Ross JS, Raggi D, Marandino L, Costa de Padua T, Crupi E, Colombo R, Colecchia M, Lucianò R, Nocera L, Moschini M, Briganti A, Montorsi F, Necchi A. Basile G, et al. Among authors: montorsi f. Clin Cancer Res. 2022 Dec 1;28(23):5107-5114. doi: 10.1158/1078-0432.CCR-22-2158. Clin Cancer Res. 2022. PMID: 36190522 Clinical Trial.
1,711 results